1-11022290-G-T

Variant summary

Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PM5PP2PP5_Very_Strong

The NM_007375.4(TARDBP):​c.881G>T​(p.Gly294Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000031 in 1,613,862 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G294A) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

TARDBP
NM_007375.4 missense

Scores

2
9
8

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4O:1

Conservation

PhyloP100: 4.63
Variant links:
Genes affected
TARDBP (HGNC:11571): (TAR DNA binding protein) HIV-1, the causative agent of acquired immunodeficiency syndrome (AIDS), contains an RNA genome that produces a chromosomally integrated DNA during the replicative cycle. Activation of HIV-1 gene expression by the transactivator Tat is dependent on an RNA regulatory element (TAR) located downstream of the transcription initiation site. The protein encoded by this gene is a transcriptional repressor that binds to chromosomally integrated TAR DNA and represses HIV-1 transcription. In addition, this protein regulates alternate splicing of the CFTR gene. A similar pseudogene is present on chromosome 20. [provided by RefSeq, Jul 2008]
MASP2 (HGNC:6902): (MBL associated serine protease 2) This gene encodes a member of the peptidase S1 family of serine proteases. The encoded preproprotein is proteolytically processed to generate A and B chains that heterodimerize to form the mature protease. This protease cleaves complement components C2 and C4 in order to generate C3 convertase in the lectin pathway of the complement system. The encoded protease also plays a role in the coagulation cascade through cleavage of prothrombin to form thrombin. Myocardial infarction and acute stroke patients exhibit reduced serum concentrations of the encoded protein. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 15 ACMG points.

PM1
In a region_of_interest Disordered (size 42) in uniprot entity TADBP_HUMAN there are 12 pathogenic changes around while only 0 benign (100%) in NM_007375.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr1-11022290-G-C is described in Lovd as [Pathogenic].
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), TARDBP. . Gene score misZ 3.7095 (greater than the threshold 3.09). Trascript score misZ 5.3115 (greater than threshold 3.09). GenCC has associacion of gene with amyotrophic lateral sclerosis type 10, amyotrophic lateral sclerosis, frontotemporal dementia with motor neuron disease.
PP5
Variant 1-11022290-G-T is Pathogenic according to our data. Variant chr1-11022290-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 21484.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-11022290-G-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TARDBPNM_007375.4 linkuse as main transcriptc.881G>T p.Gly294Val missense_variant 6/6 ENST00000240185.8 NP_031401.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TARDBPENST00000240185.8 linkuse as main transcriptc.881G>T p.Gly294Val missense_variant 6/61 NM_007375.4 ENSP00000240185 P1Q13148-1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152192
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000119
AC:
3
AN:
251162
Hom.:
0
AF XY:
0.0000221
AC XY:
3
AN XY:
135736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1461670
Hom.:
0
Cov.:
32
AF XY:
0.00000138
AC XY:
1
AN XY:
727144
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152192
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74346
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000151
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Amyotrophic lateral sclerosis type 10 Pathogenic:1Other:1
not provided, no classification providedliterature onlyGeneReviews-- -
Pathogenic, criteria provided, single submitterclinical testingMGZ Medical Genetics CenterAug 23, 2021- -
Amyotrophic lateral sclerosis type 10;C3150169:TARDBP-related frontotemporal dementia Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 19, 2024This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 294 of the TARDBP protein (p.Gly294Val). This variant is present in population databases (rs80356721, gnomAD 0.004%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individuals with amyotrophic lateral sclerosis (PMID: 19864664, 21651514, 29630989). ClinVar contains an entry for this variant (Variation ID: 21484). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TARDBP protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects TARDBP function (PMID: 25090004). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingAthena DiagnosticsAug 26, 2021The frequency of this variant in the general population is consistent with pathogenicity (Genome Aggregation Database [gnomAD], Cambridge, MA [URL: http://gnomad.broadinstitute.org]). Reports of this variant in asymptomatic individuals well past typical age of onset suggest this variant exhibits reduced penetrance (PMID: 19224587, 22722621, 31852254). This variant is statistically more frequent in affected individuals than in the general population and/or healthy controls. Experiments in patient-derived cell lines showed aberrant stress granule formation and disassembly, as well as severely impaired organelle transport along neuronal axons (PMID: 27570075, 29630989). -
TARDBP-related disorder Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJun 28, 2024The TARDBP c.881G>T variant is predicted to result in the amino acid substitution p.Gly294Val. This variant has been reported in multiple, unrelated individuals with amyotrophic lateral sclerosis (ALS) based on the literature and in our internal data (Corrado et al. 2009. PubMed ID: 19224587; Bartoletti-Stella et al. 2018. PubMed ID: 29525180; Wang et al. 2020. PubMed ID: 33159016). A different missense variant (c.881G>C, p.Gly294Ala) has also been reported to be causative of ALS (Sreedharan et al. 2008. PubMed ID: 18309045). This variant is located within the well-characterized gene hotspot known to harbor pathogenic variation. This variant is reported in 0.0026% of alleles in individuals of European (Non-Finnish) descent in gnomAD; and has been consistently classified as pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/21484/). This variant is interpreted as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Pathogenic
0.32
D
BayesDel_noAF
Pathogenic
0.32
CADD
Benign
19
DANN
Benign
0.95
DEOGEN2
Uncertain
0.50
D;D;T
Eigen
Uncertain
0.20
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.75
.;T;T
M_CAP
Uncertain
0.087
D
MetaRNN
Uncertain
0.70
D;D;D
MetaSVM
Uncertain
0.12
D
MutationAssessor
Benign
1.7
L;L;.
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-0.75
N;.;.
REVEL
Uncertain
0.53
Sift
Benign
0.26
T;.;.
Sift4G
Benign
0.27
T;.;D
Polyphen
0.14
B;B;.
Vest4
0.86
MutPred
0.82
Gain of sheet (P = 0.0266);Gain of sheet (P = 0.0266);.;
MVP
0.98
MPC
1.3
ClinPred
0.13
T
GERP RS
5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.64
gMVP
0.93

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs80356721; hg19: chr1-11082347; API